Financial Disclosure

NCCN, Pfizer Fund Four Quality Projects to Close mPCA Care Gaps

Image
NCCN, Pfizer Fund Four Quality Projects to Close mPCA Care Gaps

Plymouth Meeting, Pa. – September 18, 2026 -- The National Comprehensive Cancer Network (NCCN) Oncology Research Program has awarded funding for four quality improvement projects targeting metastatic prostate cancer (mPCA) care, backed by Pfizer Global Medical Grants (GMG).

Four institutions receive two-year grants to standardize mPCA treatment protocols

The selected projects, each set for completion within two years, will run at UT Southwestern Simmons Comprehensive Cancer Center, Georgetown University, Northwestern University's Robert H. Lurie Comprehensive Cancer Center, and Moffitt Cancer Center. Changchuan (Charles) Jiang, MD, at UT Southwestern will lead a biomarker action-loop initiative within a major U.S. safety-net cancer program. Paul Leger, MD, at Georgetown will implement multilevel interventions across the Medstar Health Network under the I-CARE PCA project.

Canaan Sells ETH Holdings, Buys Back 13.6M ADSs in August

Image
Canaan Sells ETH Holdings, Buys Back 13.6M ADSs in August

Singapore – September 18, 2026 -- Canaan Inc. (NASDAQ: CAN) liquidated its entire Ethereum position and part of its bitcoin treasury in August 2026, generating approximately US$13.9 million in cash that funded the repurchase of 13.6 million American Depositary Shares.

Canaan exits ETH position entirely, trims BTC holdings to fund buybacks

The company sold all 3,952 ETH it held along with 54 BTC at average prices of roughly US$2,400 per ETH and US$79,000 per BTC. Canaan deployed US$5.4 million of the proceeds to repurchase the ADSs in late August, lifting total shares repurchased since the start of the year to approximately 16.4 million. At month-end, Canaan held 1,868 BTC.

SMB Franchise Advisors Secures Minority Investment From Navigator Partners

Image
SMB Franchise Advisors Secures Minority Investment From Navigator Partners

Doylestown, Pa. – September 18, 2026 -- SMB Franchise Advisors has secured a strategic minority investment from principals of Navigator Partners, a private equity group based in Summit, N.J., in a deal designed to scale the franchise consultancy's support services for emerging and maturing brands.

New Board Unites SMB and Navigator Leadership

The transaction establishes a new Board of Directors combining Steve Beagelman, Founder and CEO of SMB, and Brian Luciani, Chief Growth Officer at SMB, with Navigator Managing Partners Bernard Markey and William Stewart. SMB's existing leadership team retains control of strategic decision-making and day-to-day operations.

Nomadar to Acquire Majority Stake in Fox Soccer Academy

Marshall, Texas – September 18, 2026 -- Nomadar Corp. (NASDAQ: NOMA) has signed a definitive agreement to acquire a majority interest in Fox Soccer Academy (FSA), a youth soccer organization serving approximately 2,100 players across the United States, United Kingdom and Austria.

Deal expands Nomadar's footprint across four countries

FSA operates programs in New York, North Carolina, the U.K. and Austria, co-founded by former Premier League champion Christian Fuchs and executive Raluca Gold-Fuchs. The acquisition is expected to close in the coming weeks, pending customary closing conditions and final transaction structuring.

EMD Serono Buys PostEra's AI-Designed Oral Fertility Drug Programs

Image
EMD Serono Buys PostEra's AI-Designed Oral Fertility Drug Programs

Boston – September 17, 2026 -- EMD Serono, Inc., the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has acquired two preclinical fertility drug programs from PostEra, a biotech firm built on artificial intelligence-driven small molecule discovery.

PostEra's Proton platform generated oral agonists targeting two hard-to-drug fertility receptors

The acquired programs target the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LHCGR), both used over two years by PostEra's AI platform Proton to design small molecule candidates for reproductive endocrinology. FSHR agonists were developed for ovarian stimulation in in vitro fertilization (IVF), while LHCGR agonists target male infertility and ovulation triggering in IVF protocols.

NextEra Reaffirms 8%+ EPS Growth, Targets High End of 2026 Guidance

Image
NextEra Reaffirms 8%+ EPS Growth, Targets High End of 2026 Guidance

Juno Beach, Fla. – September 17, 2026 -- NextEra Energy said it is targeting the high end of its 2026 adjusted earnings per share guidance range of $3.92 to $4.02, as senior executives prepare to meet investors through early October to detail growth prospects tied to its pending combination with Dominion Energy.

NextEra confirms 8%+ annual EPS growth through 2032 off a $3.71 base

The Juno Beach, Florida-based utility holding company reaffirmed a compound annual growth rate of 8%+ in adjusted earnings per share through 2032, using 2025 adjusted EPS of $3.71 as the baseline. NextEra said it is targeting the same 8%+ growth rate for the 2032-to-2035 period.

Dividend growth set at roughly 10% through 2026, then 6% through 2028

NextEra reiterated plans to grow dividends per share at approximately 10% annually through 2026, calculated off a 2024 base, before slowing to 6% per year from year-end 2026 through 2028.

BASF Reclaims Top Chemical Ranking as Industry Profits Crater 82%

Image
BASF Reclaims Top Chemical Ranking as Industry Profits Crater 82%

London – September 17, 2026 -- BASF retook the top spot in the ICIS Top 100 Chemical Companies ranking with $70.0 billion in 2025 sales, even as sector-wide net profits collapsed 81.9% year-on-year.

BASF overtakes Sinopec to lead global chemical rankings

The Germany-based producer displaced China's Sinopec, which posted $66.3 billion in sales for second place. US-based ExxonMobil ranked third at $53.4 billion, followed by PetroChina at $42.1 billion and Dow at $40.0 billion, according to the annual ICIS Chemical Business ranking, which converts figures to US dollars using year-end 2025 exchange rates.

NexPhase Capital Invests in EVERYWHERE Communications Platform

Image
NexPhase Capital Invests in EVERYWHERE Communications Platform

New York – September 17, 2026 -- NexPhase Capital, LP has made an investment in EVERYWHERE Communications, a mission-critical software platform serving government and enterprise clients across more than 175 countries. Terms of the deal were not disclosed.

EVERYWHERE builds resilient communications for high-risk operating environments

Founded in 2016 and headquartered in Annapolis, Maryland, EVERYWHERE operates a platform combining satellite, cellular and Wi-Fi connectivity with messaging, automated check-ins, geofencing, emergency response and location intelligence. The company serves customers in government, utilities, mining, oil and gas, and humanitarian aid sectors.

First Mining Gold Added to VanEck Junior Gold Miners GDXJ Index

Image
First Mining Gold Added to VanEck Junior Gold Miners GDXJ Index

Vancouver – September 17, 2026 -- First Mining Gold Corp. (TSX: FF; OTCQX: FFMGF; FRANKFURT: FMG) will join the MVIS Global Junior Gold Miners Index (MVGDXJ), the benchmark tracked by the VanEck Junior Gold Miners ETF (GDXJ), effective at the close of trading on September 18, 2026.

Index inclusion follows semi-annual GDXJ rebalancing

The addition comes through the MVGDXJ's scheduled semi-annual review, placing First Mining among the most liquid small-cap gold and silver mining, development and exploration companies tracked globally. The MVGDXJ is a modified market-cap-weighted index restricted to companies generating at least 50% of revenue from gold or silver, or holding at least 50% of mineral resources in those metals.

Jianpu Sets Oct. 20 Ex-Dividend Date, Triggers FINRA Due-Bill Rule

Beijing -- Jianpu Technology Inc. (OTCQB: AIJTY) confirmed that FINRA has fixed September 17, 2026 as the ex-dividend date for the special cash dividend the Chinese fintech platform announced on September 17, 2026.

Dividend payout of $0.499 per ADS exceeds a quarter of share price, forcing regulatory intervention

The special cash dividend of US$0.02495 per ordinary share, equivalent to US$0.499 per American depositary share, surpasses 25% of Jianpu's ADS trading price. Under FINRA rules, this threshold requires the ex-dividend date to fall on the first business day after the payment date rather than before it, pushing the ex-dividend date to September 17, 2026, one day after the scheduled September 17, 2026 payout.